Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.51 |
| ▸ | DRD4 | P21917 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.47 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CCR2 | P41597 | 1/20 | 0.44 |
| ▸ | GRK5 | P34947 | 1/20 | 0.44 |
| ▸ | CDK8 | P49336 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4024728 | 0.92 | CCR3 (0.57) | CCR3SIGMAR1DRD4KCNH2MCHR1 | |
| SCHEMBL4021903 | 0.91 | CCR3 (0.58) | CCR3SIGMAR1DRD4KCNH2MCHR1 | |
| SCHEMBL4028498 | 0.89 | CCR3 (0.66) | CCR3SIGMAR1DRD4KCNH2S1PR5 | |
| SCHEMBL5773270 | 0.89 | CCR3 (0.68) | CCR3SIGMAR1DRD4KCNH2CACNA1I | |
| SCHEMBL4024792 | 0.88 | CCR3 (0.57) | CCR3SIGMAR1DRD4KCNH2LMNA | |
| SCHEMBL4021803 | 0.88 | CCR3 (0.59) | CCR3SIGMAR1DRD4 | |
| SCHEMBL4024938 | 0.87 | CCR3 (0.62) | CCR3SIGMAR1DRD4ALDH1A1 | |
| SCHEMBL5832441 | 0.86 | CCR3 (0.60) | CCR3SIGMAR1DRD4KCNH2LMNA | |
| SCHEMBL7086085 | 0.86 | CCR3 (0.57) | CCR3SIGMAR1DRD4KCNH2LMNA | |
| SCHEMBL4027381 | 0.86 | CCR3 (0.59) | CCR3SIGMAR1DRD4KCNH2S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1492537-A1 | MORPHOLINE DERIVATIVES WITH A SUBSTITUTED ACETAMIDE GROUP IN THE 2-POSITION FOR USE AS CCR-3 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2005-01-05 | — | — | EP | disclosed |
| WO-2003082294-A1 | MORPHOLINE DERIVATIVES WITH A SUBSTITUTED ACETAMIDE GROUP IN THE 2-POSITION FOR USE AS CCR-3 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2003-10-09 | — | — | WO | disclosed |